Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term prophylaxis surveillance with Wilate in congenital von Willebrand disease
ISRCTN25330204Phase 4Completed
- Sponsor
- Octapharma
- Start
- Sep 2008
01
Overview
Phase 4, open-label, single-arm trial of von Willebrand factor concentrate in von Willebrand disease (VWD), sponsored by Octapharma. Primary endpoint: Bleeding frequency before and after prophylaxis at 12 months. Started Sep 2008; status: completed.
02
Drugs
von Willebrand factor concentrate
03
Conditions
von Willebrand disease (VWD)
Beyond the preview
Go deeper on ISRCTN25330204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN25330204.